Peptides
BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Its amino acid sequence mimics a fragment of body protein that plays a key role in tissue repair, angiogenesis, and anti-inflammatory pathways. In laboratory models, BPC-157 has shown the ability to accelerate tendon, ligament, muscle, and nerve regeneration while also stabilizing blood vessels and reducing oxidative stress.
KPV (Lysine-Proline-Valine) is a tripeptide that functions as an endogenous anti-inflammatory agent. It acts primarily by blocking leukotriene receptors, thereby limiting the recruitment of inflammatory cells to damaged tissues. KPV has been investigated for its protective effects in gastrointestinal mucosa, skin wounds, and neuroinflammation. When used together with BPC-157, KPV can modulate the inflammatory milieu that otherwise may slow or impede tissue regeneration.
The Science Behind Biote Senolytic Complex
Senescence is a cellular state where damaged cells cease to divide but remain metabolically active, secreting pro-inflammatory cytokines and matrix-degrading enzymes. This "senescence-associated secretory phenotype" contributes to aging and chronic disease pathology. The concept of senolytics involves selectively eliminating these senescent cells to restore tissue function and reduce inflammation.
Biote’s Senolytic Complex is a formulation that incorporates multiple bioactive peptides designed to target the key survival pathways used by senescent cells. By inhibiting anti-apoptotic signals such as BCL-2, PI3K/AKT, and NF-κB, the complex induces apoptosis specifically in senescent cells while sparing healthy ones. The resulting clearance of dysfunctional cells can improve tissue homeostasis, enhance regenerative capacity, and instapaper.com potentially delay age-related decline.
BioTE® SENOLYTIC COMPLEX
The BioTE® Senolytic Complex is a proprietary blend developed by Biote that includes BPC-157, KPV, and additional peptides that synergistically suppress senescent cell survival mechanisms. The formulation is engineered to optimize bioavailability through peptide stabilization and targeted delivery to tissues most affected by senescence—such as musculoskeletal structures, skin, and the nervous system.
Key components of the BioTE® complex:
- BPC-157 – promotes angiogenesis, reduces oxidative stress, and supports collagen synthesis.
- KPV – dampens leukotriene-mediated inflammation and protects mucosal barriers.
- Senolytic peptides (e.g., FOXO4-DRI, ABT-263 analogs) – disrupt senescent cell anti-apoptotic networks.
- Supporting molecules such as N-acetylcysteine or vitamin C derivatives to further reduce oxidative burden.
In summary, combining BPC-157 with KPV within a senolytic framework offers a multifaceted approach: BPC-157 drives tissue repair, KPV curtails inflammation, and the senolytic core eliminates damaged cells that would otherwise perpetuate chronic injury signals. The BioTE® Senolytic Complex represents an integrative strategy aimed at restoring cellular health, enhancing regeneration, and mitigating age-associated deterioration across multiple organ systems.